Happiness Biotech Group Ltd. (HAPP)

Cash Flow Statement (Annual)

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2020	2019	2018	2017	2016
Net Income	0.79	12.69	18.72	17.49	14.52
Depreciation & Amortization	0.88	0.69	0.7	0.14	0.14
Share-Based Compensation	0.78	0	0	0	0
Other Operating Activities	0.46	-2.6	-12.88	-4.69	-3.34
Operating Cash Flow	2.9	10.78	6.54	12.93	11.32
Operating Cash Flow Growth	-73.05%	64.68%	-49.40%	14.31%	-
Capital Expenditures	-2.78	-1.16	-0.28	-0.16	-1.1
Acquisitions	-9.39	0	0	0	0
Other Investing Activities	-1.05	0	0	0	0
Investing Cash Flow	-13.22	-1.16	-0.28	-0.16	-1.1
Dividends Paid	-0.38	0	0	-8.33	0
Share Issuance / Repurchase	10.97	9.34	0.63	0.22	0
Debt Issued / Paid	0.04	1.06	-0.36	-0.67	-8.43
Other Financing Activities	0.04	0	0	0	0
Financing Cash Flow	10.67	10.4	0.27	-8.78	-8.43
Net Cash Flow	2.9	18.85	5.92	4.62	1.58
Free Cash Flow	0.12	9.62	6.27	12.78	10.22
Free Cash Flow Growth	-98.74%	53.46%	-50.94%	25.03%	-
Free Cash Flow Margin	0.17%	14.78%	9.80%	20.77%	19.28%
Free Cash Flow Per Share	0.01	0.40	0.27	0.56	0.44

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).